The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

--

Today's change-- --
 Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

--

Today's change-- --
 Delayed by at least 15 minutes.

Key company metrics

  • Open--
  • Previous close--
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change--
  • Volume--
  • Average volume (10-day)--
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range-- to --
  • Beta--
  • Trailing P/E--
  • P/E 1 year forward15.11×
  • Forward PEG1.15×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
 Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue7,3847,5867,5426,532
Total other revenue--------
Total revenue7,3847,5867,5426,532
Gross profit5,0325,2575,0994,476
Total cost of revenue2,3522,3292,4432,056
Total operating expense5,6666,9916,1116,683
Selling / general / administrative2,3472,4762,2322,075
Research & development9191,017876800
Depreciation / amortization11101110
Interest expense (income), net operating--------
Unusual expense (income)1191,2766561,825
Other operating expenses, total-82-117-107-83
Operating income1,7185951,431-151
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5504231,274-318
Income after tax1,223317885-492
Income tax, total327106389174
Net income1,046257808-435
Total adjustments to net income--------
Net income before extra. items1,046257808-435
Minority interest-177-60-7757
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,046257808-435
Inc. avail. to common incl. extra. items1,046257808-435
Diluted net income1,046257809-435
Dilution adjustment--01--
Diluted weighted average shares4,8774,9574,9024,859
Diluted EPS excluding extraordinary itemsvalue per share0.210.050.17-0.09
Dividends per sharevalue per share0.190.230.190.19
Diluted normalized EPSvalue per share0.220.250.300.26